Adam Harber litigates complex civil and criminal cases, with an emphasis on the (usually distinct) areas of intellectual property and white collar criminal defense.

Adam’s civil practice focuses on representing major technology, pharmaceutical, and medical device companies in intellectual property litigation and related disputes, including litigation under the Hatch-Waxman Act and inter partes review proceedings before the USPTO.  His clients have included Pfizer, Google, Dropbox, Intel, Samsung, Alcon, and C.R. Bard.  

Adam also defends both corporate and individual clients in investigations by, and litigation against, the Department of Justice, Securities and Exchange Commission, New York Attorney General, and other government agencies.  He has experience in matters involving allegations of financial crimes, securities fraud, and anticompetitive conduct.

Adam received his B.S., with honors, from Carnegie Mellon University in 2003 and his J.D., cum laude, from Harvard Law School in 2006, where he was an editor of the Harvard Law Review and argued for the winning team in the 94th Annual Ames Moot Court Competition.  Before joining Williams & Connolly in 2007, he served as a law clerk to The Honorable D. Michael Fisher of the United States Court of Appeals for the Third Circuit.

Representative Experience

Though all cases vary and none is predictive, Adam’s experience includes:

Intellectual Property Litigation and Related Disputes

  • Obtained summary judgment for Dropbox in an action brought by Synchronoss Technologies, Inc. alleging that Dropbox’s products used by hundreds of millions of customers worldwide infringed three synchronization-related patents.
  • Served as trial counsel to Pfizer in a number of patent cases in the District of Delaware concerning the antibiotic Tygacil®, and represented Pfizer’s subsidiary Wyeth in related inter partes review proceedings.  In one of the first pharmaceutical inter partes review cases to proceed to trial and appeal, Wyeth prevailed on all claims and had the finding affirmed by the Federal Circuit.
  • Served as trial counsel to Pfizer in litigation in the District of Delaware concerning Pfizer’s platform-technology patent for abuse-resistant opioid drugs, embodied by its Embeda® product.
  • Represented Google in patent litigation in the District of Delaware and related inter partes review proceedings.
  • Represented Samsung in patent litigation in the Eastern District of Texas.
  • Defended a medical device company in patent litigation in the Northern District of California, which resulted in a successful jury verdict on all claims.  The Federal Circuit reversed the District Court’s ruling on a claim construction issue, and the case subsequently settled.
  • Advised Intel regarding several technology and IP-related disputes.

Criminal Defense and Government Investigations

  • Represented former Jefferies bond trader Jesse Litvak in appeal and retrial of securities fraud charges, which ultimately led to acquittal by the jury on, or dismissal by the government of, all charges.
  • Ongoing representation of individual client in SEC enforcement action alleging securities fraud.
  • Ongoing representation of individual client in DOJ and SEC securities fraud investigations.
  • Represented individual client in DOJ and related investigations concerning LIBOR, which have closed without settlement, charges, or an enforcement action.
  • Represented major telecommunications company in an SEC investigation, which was closed without settlement, charges, or an enforcement action.
  • Represented CEO of major technology company in indicted securities fraud matter in which the government voluntarily dismissed all charges.
  • Served as lead defense counsel in a pro bono felony trial, in which the jury returned a verdict of not guilty on all but a lesser included charge for which the client was sentenced to time served.





Recognized as "Rising Star" by Washington, D.C. Super Lawyers Magazine (2016-2019)


back to top